Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS)

Julie Scott, DNP
Julie Scott, DNP
Laugier-Hunziker Syndrome |cancerGO

What is Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS) is a rare disorder that affects the pigment of the skin and mucous membranes of the mouth. LHS is also known as idiopathic lenticular mucocutaneous pigmentation.

LHS is a benign (non-cancerous) condition and does not cause any serious health problems. The main symptom of LHS is the appearance of dark pigmentation on the lips, inside of the mouth, and sometimes on the fingers and toes. The pigmentation is typically brown or black and appears as small, flat spots or patches.

Causes:

The exact cause of LHS is unknown, but it is thought to be a combination of genetic and environmental factors. Some cases of LHS have been associated with mutations in the TERT gene, which is involved in the process of cell division and aging. Other cases have been linked to exposure to certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.

Diagnosis:

LHS is usually diagnosed based on the pigmentation pattern which is characteristic of the disorder, as well as a thorough medical history. In some cases, a skin biopsy may be performed to rule out other conditions that may cause similar symptoms.

Treatment:

Treatment for LHS is usually not necessary as the condition does not cause any health problems. However, if the pigmentation is causing cosmetic concerns, treatment options such as laser therapy, cryotherapy, and topical creams may be considered.

It is important to note that LHS does not increase the risk of developing skin cancer or other health problems. However, it is still important to practice good sun protection habits, such as wearing protective clothing and sunscreen, to prevent damage to the skin

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
Cancer Treatments
March 1, 2023

After you have received your diagnosis, you will be offered a plan to treat your cancer. There are many factors that go into recommendations, which also means there may be changes along the way, and deviations from the initial plan. Treatments are tailored to your specific tumor type, grade, pathology,…

Jenni Daniel BSN, RN

author

Articles
Understanding Neurofibromatosis (NF): Causes, Symptoms, and Treatments
January 23, 2023

What is Neurofibromatosis (NF)? Neurofibromatosis (NF)  is a genetic disorder affecting nerve cell growth and development. It is characterized by the development of benign tumors called neurofibromas on nerve tissue and other symptoms. There are three types of neurofibromatosis: NF1, NF2, and Schwannomatosis. NF1 is the most common type of…

Julie Scott, DNP

author

Articles
What You Should Know About Breast Implants and BIA-ALCL.
January 23, 2023

What is Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)? Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare type of non-Hodgkin's lymphoma that can develop around breast implants. The lymphoma cells typically form a fluid-filled capsule with scar tissue around the implant. It is a rare condition, with less…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice